Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof

Details for Australian Patent Application No. 2002240287 (hide)

Owner Genetics Institute, LLC

Inventors Shaw, Gray D.; Sako, Dianne, S.; Kumar, Ravindra; McDonagh, Tom; Sullivan, Francis, X.

Agent Cullen & Co

Pub. Number AU-B-2002240287

PCT Pub. Number WO2002/063003

Priority 60/266,838 06.02.01 US

Filing date 6 February 2002

Wipo publication date 19 August 2002

Acceptance publication date 24 August 2006

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002240287

24 August 2006 Application Accepted

  Published as AU-B-2002240287

21 December 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002240288-Method and apparatus for improving mitral valve function

2002240286-DETECTION OF POLYMORPHISMS IN THE HUMAN 5-LIPOXYGENASE GENE